abstract |
The present invention includes compounds of formula (I), wherein: X, R 1 , R 2 , R 3 and R 4 are as defined in this specification. The present invention also includes methods of preventing, treating or ameliorating syndromes, disorders or diseases wherein said syndromes, disorders or diseases are type II diabetes, obesity and asthma. The invention also includes a method of inhibiting CCR2 activity in a mammal by administering a therapeutically effective amount of at least one compound of formula (I). |